FindTrial
Sign In

Different approaches to the diagnosis of blood cancer

Morpho-immuno-photonic approach to the diagnosis of B cell Acute Lymphoblastic Leukaemia. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/09/074521
Enrollment
20
Registered
2024-09-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C910- Acute lymphoblastic leukemia [ALL]

Interventions

Control Intervention1: nil: nil

Sponsors

Vision Group on Science and Technology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Newly detected cases of B cell ALL all age groups and genders.

Exclusion criteria

Exclusion criteria: Patients with hematological malignancies other than B cell ALL, and patients who are on follow-up beyond the post-induction status of standard chemotherapy.

Design outcomes

Primary

MeasureTime frame
Raman spectroscopy, confocal immunofluorescence imaging and immune flow cytometry for diagnosis of B cell acute lymphoblastic leukaemiaTimepoint: Baseline—

Secondary

MeasureTime frame
spectral changes in the bone marrow samples of B cell acute lymphoblastic leukemiaTimepoint: baseline—

Countries

India

Contacts

Public ContactDr Uttara Chakraborty

Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal

vasudev.bhat@manipal.edu9619114703

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026